Biden's Move to Combat Obesity Helped Eli Lily and Novo Nordisk Shares Higher
President Joe Biden's term ends in 2025. His administration proposed a new rule to address obesity by expanding Medicare and Medicaid coverage for weight-loss drugs Ozempic and Mounjaro. This led to a rise in stock prices for Novo Nordisk and Eli Lilly.